Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Verisk Analytics, Inc. insiders sold a net $6.2M of stock across 181 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
27 earlier Form 4 trades (code P or S) here by this insider (27 sales), the last on Sep 15, 2026.
The trade is 2.3% of the 17,584 shares held after it.
1 other insider sold within 30 days.
494 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer Mann Elizabeth sold about $73.9K of VRSK under a 10b5-1 plan on Oct 15, 2026; 1 other insider sold within 30 days and 494 funds added in the latest 13F quarter.
31 earlier Form 4 trades (code P or S) here by this insider (31 sales), the last on Sep 1, 2026.
The trade is 3.6% of the 98,490 shares held after it.
1 other insider sold within 30 days.
494 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Shavel Lee sold about $603.4K of VRSK under a 10b5-1 plan on Oct 1, 2026; 1 other insider sold within 30 days and 494 funds added in the latest 13F quarter.
26 earlier Form 4 trades (code P or S) here by this insider (26 sales), the last on Aug 17, 2026.
The trade is 2.2% of the 17,984 shares held after it.
1 other insider sold within 30 days.
494 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer Mann Elizabeth sold about $74.0K of VRSK under a 10b5-1 plan on Sep 15, 2026; 1 other insider sold within 30 days and 494 funds added in the latest 13F quarter.
30 earlier Form 4 trades (code P or S) here by this insider (30 sales), the last on Aug 3, 2026.
The trade is 3.6% of the 98,490 shares held after it.
1 other insider sold within 30 days.
494 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Shavel Lee sold about $683.8K of VRSK under a 10b5-1 plan on Sep 1, 2026; 1 other insider sold within 30 days and 494 funds added in the latest 13F quarter.
25 earlier Form 4 trades (code P or S) here by this insider (25 sales), the last on Jul 15, 2026.
The trade is 2.2% of the 18,384 shares held after it.
2 other insiders sold within 30 days.
494 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer Mann Elizabeth sold about $72.0K of VRSK on Aug 17, 2026; 2 other insiders sold within 30 days and 494 funds added in the latest 13F quarter.
181 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
VRSK planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Daffan Nicholas
Filed 2026-10-20
$3.2M
Daffan Nicholas
Filed 2026-10-15
$1.6M
Mann Elizabeth
Filed 2026-10-15
$73.9K
Shavel Lee
Filed 2026-10-01
$603.4K
Daffan Nicholas
Filed 2026-09-21
$179.7K
VRSK mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Eaton Vance Atlanta Capital Focused Growth Fund
$28.5M position · as of 2026-06-30
6.1%
Nomura Focused Large Growth ETF
$12.2M position · as of 2026-06-30
4.6%
Calvert Equity Fund
$145.1M position · as of 2026-06-30
4.3%
Virtus KAR Mid-Cap ETF
$2.0M position · as of 2026-07-31
4.3%
Invesco Bloomberg Financial Data Providers ETF
$2.2M position · as of 2026-05-31
4.2%
Sterling Capital Special Opportunities Fund
$11.5M position · as of 2026-06-30
3.3%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Government contracts
Award ceilings over the contract's life, subsidiaries included.
Not annual revenue (USASpending.gov).
Department Of Health And Human Services
INSURANCE DATA MATCH SERVICES TASK ORDER FOR ACF-OCSE · 2018-08-01
$6.9M
Federal awards ≥ $25M in the last 90 days, matched via the SAM.gov parent registry
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $6.2M sold by insiders over 180 days, 494 funds added last quarter, 2 House member(s) bought in 12 months, disclosed weeks after the trade, $12.7M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$3.1B
four quarters, 2025-04-01 to 2026-03-31
Revenue, TTM VRSK
FY Dec 2025
$3.1B
FY Dec 2024
$2.9B
FY Dec 2023
$2.7B
FY Dec 2022
$2.5B
FY Dec 2021
n/a
Mar 2026
$782.6M
Dec 2025
$778.8M
Sep 2025
$768.3M
Jun 2025
$772.6M
Mar 2025
$753.0M
Dec 2024
$735.6M
Sep 2024
$725.3M
Jun 2024
$716.8M
At each fiscal year end
Single quarter
Net margin, TTM
+29.3%
net income over revenue, 2025-04-01 to 2026-03-31
Net margin, TTM VRSK
FY Dec 2025
+29.6%
FY Dec 2024
+33.3%
FY Dec 2023
+22.9%
FY Dec 2022
+38.2%
FY Dec 2021
n/a
Mar 2026
+29.9%
Dec 2025
+25.3%
Sep 2025
+29.4%
Jun 2025
+32.8%
Mar 2025
+30.8%
Dec 2024
+28.6%
Sep 2024
+30.3%
Jun 2024
+43.0%
At each fiscal year end
Single quarter
Free cash flow, TTM
$1.1B
operating cash flow minus capex, 2025-04-01 to 2026-03-31
Free cash flow, TTM VRSK
FY Dec 2025
$1.2B
FY Dec 2024
n/a
FY Dec 2023
$830.7M
FY Dec 2022
$784.3M
FY Dec 2021
$887.3M
Mar 2026
$326.4M
Dec 2025
$276.1M
Sep 2025
$336.1M
Jun 2025
$188.7M
Mar 2025
$391.0M
Dec 2024
$200.0M
Sep 2024
$240.7M
Jun 2024
$153.9M
At each fiscal year end
Single quarter
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Debt to equity VRSK
FY Dec 2025
20.33x
FY Dec 2024
36.02x
FY Dec 2023
9.35x
FY Dec 2022
2.94x
FY Dec 2021
1.52x
Mar 2026
n/a
Dec 2025
20.33x
Sep 2025
12.52x
Jun 2025
10.43x
Mar 2025
30.51x
Dec 2024
36.02x
Sep 2024
10.22x
Jun 2024
7.13x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.31x
TTM operating cash flow over long-term 2026-03-31 plus current 2026-03-31
Cash flow to debt VRSK
FY Dec 2025
0.23x
FY Dec 2024
n/a
FY Dec 2023
0.37x
FY Dec 2022
0.21x
FY Dec 2021
0.27x
Mar 2026
0.31x
Dec 2025
0.23x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
0.37x
Jun 2024
0.35x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
average equity is zero or negative
Return on equity VRSK
FY Dec 2025
+444.0%
FY Dec 2024
+467.3%
FY Dec 2023
+59.7%
FY Dec 2022
+41.8%
FY Dec 2021
+24.2%
Mar 2026
n/a
Dec 2025
+444.0%
Sep 2025
+272.5%
Jun 2025
+246.9%
Mar 2025
+479.2%
Dec 2024
+467.3%
Sep 2024
+269.5%
Jun 2024
+245.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+18.7%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on assets VRSK
FY Dec 2025
+17.4%
FY Dec 2024
+22.2%
FY Dec 2023
+10.9%
FY Dec 2022
+12.9%
FY Dec 2021
+8.7%
Mar 2026
+18.7%
Dec 2025
+17.4%
Sep 2025
+17.1%
Jun 2025
+19.2%
Mar 2025
+20.2%
Dec 2024
+22.2%
Sep 2024
+20.7%
Jun 2024
+19.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+33.5%
operating income after a 23.1% effective tax rate, over long-term 2026-03-31 plus current 2026-03-31 plus average of 2025-03-31 and 2026-03-31 minus cash
Return on invested capital VRSK
FY Dec 2025
+19.8%
FY Dec 2024
+27.6%
FY Dec 2023
+22.8%
FY Dec 2022
+15.9%
FY Dec 2021
+10.2%
Mar 2026
+33.5%
Dec 2025
+19.8%
Sep 2025
+27.2%
Jun 2025
+33.7%
Mar 2025
+30.5%
Dec 2024
+27.6%
Sep 2024
+31.1%
Jun 2024
+30.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+38.3%
operating income (EBIT proxy) over average of 2025-03-31 and 2026-03-31 minus current liabilities
Return on capital employed VRSK
FY Dec 2025
+38.8%
FY Dec 2024
+37.9%
FY Dec 2023
+27.5%
FY Dec 2022
+26.5%
FY Dec 2021
+15.1%
Mar 2026
+38.3%
Dec 2025
+38.8%
Sep 2025
+37.3%
Jun 2025
+36.0%
Mar 2025
+35.0%
Dec 2024
+37.9%
Sep 2024
+34.9%
Jun 2024
+33.5%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
28.57x
close 2026-10-27 over four quarters of diluted EPS, 2025-04-01 to 2026-03-31
P/E, trailing VRSK
FY Dec 2025
34.47x
FY Dec 2024
41.11x
FY Dec 2023
56.87x
FY Dec 2022
29.50x
FY Dec 2021
56.06x
Mar 2026
28.88x
Dec 2025
34.47x
Sep 2025
38.34x
Jun 2025
48.00x
Mar 2025
43.58x
Dec 2024
41.11x
Sep 2024
41.87x
Jun 2024
43.83x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$28.5B
market value at close 2026-10-27 on 2026-04-24 shares, plus long-term 2026-03-31 plus current 2026-03-31, minus cash 2026-03-31
Enterprise value VRSK
FY Dec 2025
$35.3B
FY Dec 2024
$42.2B
FY Dec 2023
$37.2B
FY Dec 2022
$32.6B
FY Dec 2021
$41.0B
Mar 2026
$30.1B
Dec 2025
$35.3B
Sep 2025
$37.7B
Jun 2025
$46.2B
Mar 2025
$44.4B
Dec 2024
$42.2B
Sep 2024
$40.8B
Jun 2024
$40.9B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+4.6%
TTM free cash flow over market value at close 2026-10-27
FCF yield VRSK
FY Dec 2025
+3.8%
FY Dec 2024
n/a
FY Dec 2023
+2.4%
FY Dec 2022
+2.8%
FY Dec 2021
+2.4%
Mar 2026
+4.3%
Dec 2025
+3.8%
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
+2.4%
Jun 2024
+2.2%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -4%, PEG needs growth
PEG, trailing VRSK
FY Dec 2025
n/a
FY Dec 2024
0.69x
FY Dec 2023
n/a
FY Dec 2022
0.63x
FY Dec 2021
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
15.34x
Jun 2025
8.68x
Mar 2025
1.58x
Dec 2024
0.69x
Sep 2024
0.48x
Jun 2024
0.52x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
VRSK ranks highest on profitability (92nd percentile) and risk and compliance (76th), and lowest on insider conviction (17th), among Software & IT peers.
Profitability
92
Inputs
Return on equityaverage equity is zero or negative
Return on assets+18.7% · 90 pct, sector of 381
Return on invested capital+33.5% · 90 pct, sector of 78
Return on capital employed+38.3% · 97 pct, sector of 294
Financial health
55
Inputs
Debt to equityequity is zero or negative, the ratio has no meaning
Cash flow to debt0.31x · 55 pct, sector of 241
Growth
53
Inputs
Revenue growth, YoY+6.6% · 43 pct, sector of 480
Backlog growth, YoY+16.5% · 63 pct, sector of 182
Insider conviction
17
Inputs
Net Form 4 buying (codes P and S), 180d-$4.8M · 34 pct, sector of 284
Insider buyers, 180d0 · 0 pct, sector of 290
Institutional and government
51
Inputs
Funds adding, latest quarter494 · 93 pct, sector of 415
Congress net buyers, 365d-1 · 11 pct, sector of 72
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$350K · 50 pct, sector of 85
Risk and compliance
76
Inputs
Short interest, % of float+3.4% · 60 pct, sector of 528
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+4.0% · 91 pct, sector of 316
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
VRSK filings, in plain words
Are Verisk Analytics insiders buying or selling VRSK?
In the 180 days to 2026-10-28, Verisk Analytics insiders were net sellers, a net $6.2M across purchases and sales reported on Form 4, by 5 sellers.
Have members of Congress traded VRSK?
Yes. In the year to 2026-10-28, 2 House members disclosed buying VRSK and 3 House members disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-08-18.
Are there planned insider sales of VRSK?
Yes. 14 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $12.7M of stock; the latest, by Daffan Nicholas, was filed 2026-10-20.
Read the full summary
In the 180 days to 2026-10-28, Verisk Analytics insiders were net sellers of VRSK, a net $6.2M across purchases and sales reported on Form 4 by 5 sellers. 27% of the 15 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. In the year to 2026-10-28, 2 members of Congress disclosed buying VRSK and 3 members disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-08-18. Insiders filed 14 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $12.7M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.